Registered number
06087279
PACS (Bedmond) Limited
Filleted Accounts
31 March 2024
PACS (Bedmond) Limited
Registered number: 06087279
Balance Sheet
as at 31 March 2024
Notes 2024 2023
£ £
Current assets
Debtors 3 759,799 664,019
Investments held as current assets 4 964,685 909,010
Cash at bank and in hand 7,738 19,550
1,732,222 1,592,579
Creditors: amounts falling due within one year 5 (1,514,554) (1,413,214)
Net current assets 217,668 179,365
Total assets less current liabilities 217,668 179,365
Provisions for liabilities (41,831) (32,321)
Net assets 175,837 147,044
Capital and reserves
Called up share capital 100 100
Revaluation reserve 6 178,334 137,789
Profit and loss account (2,597) 9,155
Shareholders' funds 175,837 147,044
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Ms S M Donovan
Director
Approved by the board on 11 February 2025
PACS (Bedmond) Limited
Notes to the Accounts
for the period from 1 March 2023 to 31 March 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Financial costs
Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Current and deferred taxation
The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
• The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
• Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Financial instruments
The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Investments in non-derivative instruments that are equity to the issuer are measured:
• at fair value with changes recognised in the Profit and loss account if the shares are publicly traded or their fair value can otherwise be measured reliably;
• at cost less impairment for all other investments.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Profit and loss account.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 2 2
3 Debtors 2024 2023
£ £
Other debtors 759,799 664,019
4 Investments held as current assets 2024 2023
£ £
Fair value
Listed investments 964,685 909,010
Increase/(decrease) in fair value included in the profit and loss account for the period
Listed investments 61,509 (82,275)
5 Creditors: amounts falling due within one year 2024 2023
£ £
Other creditors 1,514,554 1,413,214
6 Revaluation reserve 2024 2023
£ £
At 1 March 2023 137,789 217,410
Gain/(loss) on revaluation investments 40,545 (79,621)
At 31 March 2024 178,334 137,789
7 Related party transactions
At the balance sheet date, £1,507,679 (2023 - £1,407,000) was owed to a company under common control. Interest of £100,680 (2023 - £22,490) was charged by this company to PACS (Bedmond) Limited on this balance during the period. A management charge of £95,500 (2023- £22,500) was also charged to this company by PACS (Bedmond) Limited during the period and at the balance sheet date a balance of £701,419 (2023 - £605,919) was owed from this company.

At the balance sheet date a balance of £8,000 (2023 - £8,000) was due from a company in which a director has a controlling interest.
8 Other information
PACS (Bedmond) Limited is a private company limited by shares and incorporated in England. Its registered office is:
10 Breakspear Place
Abbots Langley
Hertfordshire
WD5 0QF
PACS (Bedmond) Limited 06087279 false 2023-03-01 2024-03-31 2024-03-31 VT Final Accounts July 2024 Ms S M Donovan No description of principal activity 06087279 2022-03-01 2023-02-28 06087279 core:RevaluationReserve core:LandBuildings 2022-03-01 2023-02-28 06087279 core:WithinOneYear 2023-02-28 06087279 core:ShareCapital 2023-02-28 06087279 core:OtherReservesSubtotal 2023-02-28 06087279 core:RetainedEarningsAccumulatedLosses 2023-02-28 06087279 core:RevaluationReserve 2022-02-28 06087279 2023-03-01 2024-03-31 06087279 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-03-31 06087279 bus:AuditExemptWithAccountantsReport 2023-03-01 2024-03-31 06087279 bus:Director40 2023-03-01 2024-03-31 06087279 1 2023-03-01 2024-03-31 06087279 2 2023-03-01 2024-03-31 06087279 core:RevaluationReserve core:LandBuildings 2023-03-01 2024-03-31 06087279 countries:England 2023-03-01 2024-03-31 06087279 bus:FRS102 2023-03-01 2024-03-31 06087279 bus:FilletedAccounts 2023-03-01 2024-03-31 06087279 2024-03-31 06087279 core:WithinOneYear 2024-03-31 06087279 core:ShareCapital 2024-03-31 06087279 core:OtherReservesSubtotal 2024-03-31 06087279 core:RetainedEarningsAccumulatedLosses 2024-03-31 06087279 core:RevaluationReserve 2024-03-31 06087279 2023-02-28 06087279 core:RevaluationReserve 2023-02-28 iso4217:GBP xbrli:pure